Nikola Shares Gain 18% After Bulk Transport Co. Signs LOI to Buy 100 Zero-Emission Trucks
Source: Streetwise Reports  (12/23/21)
Nikola Corp. shares traded higher after the firm reported that Heniff Transportation Systems LLC signed a letter of intent to purchase 100 zero-emission trucks from Thompson Truck Center and Nikola. More >

Wingdam Close to Panning in ‘One of the Richest Placer Deposits in British Columbia History’
Source: Streetwise Reports  (12/22/21)
Near Quesnel, B.C., a small Canadian company is about to take placer gold mining public. It’s been a long road, but it looks like British Columbia’s Cariboo region could see another gold rush more than 160 years after the first. More >

Renewable Energy Co. Plans to Expand Capacity to 30GW by 2025
  (12/21/21)
In a December 15 research note, H.C. Wainwright & Co. Equity Research Analysts Sameer Joshi and Amit Dayal commented that community and commercial solar power company UGE International Ltd. (UGE:TSX.V; UGEIF:OTCQB) is "positioned to capture value across the project lifecycle." More >

Market Expert Calls Uranium and Vanadium Company a Buy
Source: Michael Ballanger  (12/21/21)
Industry observer Michael Ballanger explains why he has Western Uranium and Vanadium Corp. on his buy list. More >

Leading Computer Memory and Storage Manufacturer Expects Record Revenue
Source: Streetwise Reports  (12/21/21)
Micron Technology Inc. shares traded 11% higher after the company reported Q1/22 financial results and stated that it was on a path toward record revenue and solid profitability in FY/22. More >

Analyst Highlights Top Picks in Biotech for 2022
  (12/20/21)
Aldeyra Therapeutics, in the ophthalmology space, and SQZ Biotechnologies, in the cell therapy sector, have "advantages that their specific approaches allow," noted a BTIG report. More >

Remembering Wharton: Detecting When the Fed Turns 'For or Against You'
Source: Michael Ballanger  (12/20/21)
Precious metals expert Michael Ballanger remembers lessons learned years ago from a three-year course in "Stocks and Bonds 101," and how those principles still apply today. More >

FDA Grants Approval for CNS-Focused Biopharma Firm's Bipolar Disorder Drug
Source: Streetwise Reports  (12/20/21)
Intra-Cellular Therapies Inc. shares traded 19% higher to a new 52-week high after the company reported the U.S. FDA has approved the use of its CAPLYTA® (lumateperone) for treatment of adults with bipolar depression. More >

Dolly Varden Silver: Consolidating a High-Grade Gold-Silver District In British Columbia
Source: The Critical Investor  (12/19/21)
After Dolly Varden Silver announced the transaction with Fury Gold Mines regarding the Homestake Ridge Project, the Critical Investor looked into future potential coming from combining Homestake with the Dolly Varden Project, and exploration potential. More >

Thoma Bravo Makes $2.6 Billion Offer to Take Bottomline Technologies Private
Source: Streetwise Reports  (12/18/21)
Shares of Bottomline Technologies Inc. traded 15% higher after the company reported it agreed to be acquired by private equity firm Thoma Bravo for $57.00 per share in cash. More >

Outlook Positive After Agricultural Firm Beats Expectations
Source: Streetwise Reports  (12/17/21)
Alico "offers a compelling opportunity" given expectations for increased production and pricing and continued dividends paid to shareholders, noted a ROTH Capital Partners report. More >

Investment Opportunity: Fast Growing Data Firm Helping Global Brands Retain Customers
Source: Streetwise Reports  (12/17/21)
In this Dec. 15 episode of Streetwise Live! viewers learned about Datable Technology, what it does, why it is a compelling story and why two former Disney executives invested in it. They, Mike Ridgewell and Marc Reintjes, were on the panel along with Datable Chairman Kim Oishi and eResearch analyst Chris Thompson. More >

Co. Launches Pivotal Phase in Alzheimer's Agitation Drug's Trial
  (12/17/21)
BioXcel Therapeutics' lead drug candidate for agitation in Alzheimer's disease patients could serve a substantial market, noted an H.C. Wainwright & Co. report. More >

Analyst Says Regeneron Could Be 'Biotech Champion'
  (12/17/21)
Regeneron Pharmaceuticals Inc.'s stock was up 36% in 2021 while the NASDAQ Biotechnology Index remained flat, Oppenheimer analyst Hartaj Singh reported in a Dec. 16 research note. More >

Fabled Silver Gold Spins Out Copper Assets, 'Looks Like a Good Time to Buy'
Source: Streetwise Reports  (12/16/21)
Just in time for Christmas, one junior explorer drilling off concessions in a historic silver camp in Mexico is spinning its copper assets into a red metal play in northern British Columbia; and it just announced positive new drill results at its Mexico project. More >

Alianza Minerals, Cloudbreak Discovery Acquire and Option Out Projects
Source: The Critical Investor  (12/16/21)
The Critical Investor catches up with CEO Jason Weber of Alianza Minerals about the company's latest endeavors with Cloudbreak Discovery and the status of their other projects. More >

Co.'s Shares Gain 27% After FDA Nears Drug Approval
Source: Streetwise Reports  (12/16/21)
Shares of Calliditas Therapeutics AB traded higher after the company reported the U.S. FDA granted accelerated approval for its TARPEYOâ„¢ (budesonide) to reduce proteinuria in IgA nephropathy. More >

A Critical Q & A With Golden Independence CEO Christos Doulis
Source: The Critical Investor  (12/16/21)
With the recently earned-in ownership of 51% in the Independence Gold project, the PEA coming up and potentially a much more important catalyst in Q1 2022, the Critical Investor felt it was time to conduct an interview with CEO Christos Doulis. More >

New Team-Up Forges a Comprehensive Electronic Materials Platform
Source: Streetwise Reports  (12/15/21)
CMC Materials Inc. shares traded 33% higher after the semiconductor materials company reported it agreed to be acquired by Entegris Inc. in a combination cash and stock deal valued at approximately $6.5 billion. More >

Explorer Gaining Momentum in Push for New Discoveries at Ecuador Property
Source: Streetwise Reports  (12/14/21)
Critical and precious metals explorer Aurania Resources Ltd. is methodically moving forward with is exploration program at its Lost Cities-Cutucu Project which has been shown to host significant amounts of zinc, copper, silver and other elements. Noble Capital Markets advised that the firm plans to begin exploration work at its Awacha target site in mid-December and is building momentum as it moves into 2022. More >

Companies Partner to Reach New Depths in Nevada
Source: Streetwise Reports  (12/14/21)
Nevada Exploration Inc. is looking to another local company to help shoulder the risk of gold exploration in the Silver State. More >

Terminix to Merge With Rentokil to Create Global Pest Control Leader
Source: Streetwise Reports  (12/14/21)
Terminix Global Holdings Inc. shares traded 18% higher after the company reported it has entered into a definitive agreement to be acquired by Rentokil Initial Plc. in a cash and stock transaction valued at US$6.7 billion, or about US$55/share. More >

Target Price Raised on Biotech Based on Management Update
  (12/13/21)
During its recent R&D Day, Prometheus Biosciences announced new strong trial data, another new indication for its lead therapeutic candidate and progress in developing a subcutaneous formulation of it, according to an Oppenheimer report. More >

Resource Firm Eyes Three New Drill Targets at B.C. Gold Project
Source: Streetwise Reports  (12/13/21)
Omineca Mining and Metals will focus on the placer gold component of the Wingdam project throughout 2021 then next year also take on exploring the newly identified hardrock gold targets there, a Research Capital Corporation report noted. More >

Software Co. Reports 91% YoY Increase in Q3/21 Revenues
Source: Streetwise Reports  (12/13/21)
Vancouver-based software and technology company Datable Technology Corp. is helping consumer packaged goods companies collect data from consumers who opt-in to their apps, promotions, contests, and loyalty programs. eResearch Corp. indicated that it is initiating coverage of the company with a "Speculative Buy" rating as it is now in the midst of a rapid revenue growth cycle. More >